Health-Related Quality of Life in End-Stage Renal Disease Patients and Healthy Individuals

  • Niyan Hakeem Ismael1 1. Faculty of Medical Sciences, College of Nursing, University of Sulaimani, Urological Department. Sulaymaniyah, Iraq
  • Aso Omer Rashid 2. Faculty of Medical Sciences, College of Medicine, University of Sulaimani Urological Department, Sulaymaniyah, Iraq
Keywords: End-Stage Renal Disease; Health-Related Quality of Life; Kidney Transplantation; Chronic Disease


Background: Health-related quality of life (HRQOL) is an important outcome measure in patients with end-stage renal disease (ESRD). HRQOL is assumed to improve with kidney transplantation and compared to hemodialysis. However, there is no evidence regarding HRQOL to support the optimal treatment choice for patients on hemodialysis who hesitate opting for transplantation. Therefore, this study aims to compare HRQOL between patients with ESRD and healthy individuals. Materials and Methods: This case-control study was performed of 50 patients with ESRD under hemodialysis and 100 healthy participants as controls. HRQOL was assess using the SF-36 questionnaire. Data was analysis by using linear regression to compared HRQOL between groups, and adjusted for age, gender, dialysis duration. Results: Most of the patients were males (62%) and aged 21 to 60 years old (82%). The patients and healthy subjects were significantly different in terms of the presence of chronic diseases (P<0.05). ESRD patients had a significantly lower level of satisfaction with health and function, family and friends, and social and psychological functions. The patients’ quality of life was not significantly affected by their demographic characteristics, including age, gender, educational level, marital status, and financial status. However, there was a significant association between chronic disease and HRQOL among ESRD (P=0.0001). Conclusion: ESRD has a remarkably negative effect on the patients’ quality of life and satisfaction with important domains of life. HRQOL among patients with end-stage renal disease can be affected by the associated chronic diseases. [GMJ.2020;9:e1987] DOI:10.31661/gmj.v9i0.1987  


Lacson E Jr., Xu J, Lin SF, Dean SG, Lazarus JM, Hakim RM. A comparison of SF-36 and SF-12 composite scores and subsequent hospitalization and mortality risks in long-term dialysis patients. Clin J Am Soc Nephrol. 2010; 5(2):252-60.

PMid:20019120 PMCid:PMC2827595

Mapes DL, Lopes AA, Satayathum S, McCullough KP, Goodkin DA, Locatelli F, et al. Health-related quality of life as a predictor of mortality and hospitalization: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int. 2003; 64(1):339-49.


Lowrie EG, Curtin RB, LePain N, Schatell D. Medical outcomes study short form-36: a consistent and powerful predictor of morbidity and mortality in dialysis patients. Am J Kidney Dis. 2003; 41(6):1286-92.

Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH. Association among SF36 quality of life measures and nutrition, hospitalization, and mortality in hemodialysis. J Am Soc Nephrol. 2001; 12 (12):2797-806.

Mittal SK, Ahern L, Flaster E, Maesaka JK, Fishbane S. Self-assessed physical and mental function of haemodialysis patients. Nephrol Dial Transplant. 2001; 16(7):1387-94.


Tonelli M, Wiebe N, Knoll G, Bello A, Browne S, Jadhav D, et al. Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes. AmJTransplant. 2011; 11(10):2093-109.


Pierratos A, Ouwendyk M, Francoeur R, Vas S, Raj DS, Ecclestone AM, et al. Nocturnal hemodialysis: three-year experience. J Am Soc Nephrol. 1998; 9(5):859-68.

Ojo A. Addressing the global burden of chronic kidney disease through clinical and translational research. Trans Am Clin Climatol Assoc. 2014;125:229-43.

Cheng X, Nayyar S, Wang M, et al. Mortality rates among prevalent hemodialysis patients in Beijing: A comparison with USRDS data. Nephrol Dial Transplant. 2013;28:724-32.


Elsharif ME. Mortality rate of patients with end-stage renal disease on regular hemodialysis: A single center study. Saudi J Kidney Dis Transpl. 2011;22:594-6.

Wallen MD, Radhakrishnan J, Appel G, Hodgson ME, Pablos-Mendez A. An analysis of cardiac mortality in patients with new-onset end-stage renal disease in New York State. Clin Nephrol. 2001;55:101-8.

Valderrábano F, Jofre R, López-Gómez JM. Quality of life in end-stage renal disease patients. Am J Kidney Dis. 2001;38:443-64.


Wu AW, Fink NE, Cagney KA, et al. Developing a health-related quality-of-life measure for end-stage renal disease: The CHOICE Health Experience Questionnaire. Am J Kidney Dis. 2001;37:11-21.


Centers for Disease Control and Prevention. Measuring healthy days: Population assessment of health related quality of life. Atlanta, Georgia: US Department of Health and Human Services, National Centers for Disease Prevention and Health Promotion, Division of Adult and Community Health, CDC; 2000. p. 4-9.

Ware JE Jr, Gandek B. Overview of the SF-36 health survey and the international quality of life assessment (IQOLA) project. J Clin Epidemiol. 2000;51:903-12.

Pagels AA, Söderkvist BK, Medin C, Hylander B, Heiwe S. Health-related quality of life in different stages of chronic kidney disease and at initiation of dialysis treatment. Health Qual Life Outcomes. 2012;10:71.

PMid:22710013 PMCid:PMC3511211

Spiegel BM, Melmed G, Robbins S, Esrailian E. Biomarkers and health-related quality of life in end-stage renal disease: A systematic review. Clin J Am Soc Nephrol. 2008;3:1759-68.

PMid:18832106 PMCid:PMC2572281

Mapes DL, Bragg-Gresham JL, Bommer J, et al. Health-related quality of life in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2004;44 5 Suppl 2:54-60.

Hochman ME, Watt JP, Reid R, O'Brien KL. The prevalence and incidence of end-stage renal disease in Native American adults on the Navajo reservation.Kidney Int. 2007; 71:931-937.


Stats F. National chronic kidney disease fact sheet, 2017. US Department of Health and Human Services, Centers for Disease Control and Prevention; 2017.

Ishani A, Grandits GA, Grimm RH, et al. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial. J Am Soc Nephrol. 2006;17(5):1444-1452.


US Renal Data System 2007 annual data report. Retrieved on July 25, 2019 from:

Hsu CY, Iribarren C, McCulloch CE, Darbinian J, Go AS. Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med. 2009;169(4):342-350.

PMid:19237717 PMCid:PMC2727643

Wu PP, Kor CT, Hsieh MC, Hsieh YP. Association between End-Stage Renal Disease and Incident Diabetes Mellitus-A Nationwide Population-Based Cohort Study. J Clin Med. 2018;7(10):343.

PMid:30314341 PMCid:PMC6210467

Narres M, Claessen H, Droste S, et al. The Incidence of End-Stage Renal Disease in the Diabetic (Compared to the Non-Diabetic) Population: A Systematic Review. PLoS One. 2016;11(1):e0147329.

PMid:26812415 PMCid:PMC4727808

Alalawi F, Ahmed M, AlNour H, Noralla M, Alhadari A. Epidemiology of end-stage renal disease in Dubai: Single-center data. Saudi J Kidney Dis Transpl. 2017; 28(5):1119-25.


Goh ZS, Griva K. Anxiety and depression in patients with end-stage renal disease: impact and management challenges - a narrative review. Int J Nephrol Renovasc Dis. 2018;11:93-102.

PMid:29559806 PMCid:PMC5856029

Kutner NG. Comment on: Quality of Life, Perceptions, and Health Satisfaction of Older Adults with End-Stage Renal Disease. J Am Geriatr Soc. 2017;65(10):2330-2331.

PMid:28832900 PMCid:PMC5657235

Gerogianni S, Babatsikou F, Gerogianni G, Koutis C, Panagiotou M, Psimenou E. Social life of patients undergoing haemodialysis. Int J Caring Sci. 2016; 9:122-134

Rostami Z, Einollahi B, Lessan-Pezeshki M, Soleimani Najaf Abadi A, Mohammadi Kebar S, Shahbazian H, et al. Health-related quality of life in hemodialysis patients: an Iranian multi-center study. Nephrourol Mon. 2013;5(4):901-12.

PMid:24350090 PMCid:PMC3842562

Vanholder R, Annemans L, Brown E et al. Reducing the costs of chronic kidney disease while delivering quality health care: a call to action. Nat Rev Nephrol 2017; 13: 393-409


Tel H, Tel H. Quality of life and social support in hemodialysis patients. Pak J Med Sci. 2011;27(1):64-7.

Cruz MC, Andrade C, Urrutia M, Draibe S, Nogueira-Martins LA, Sesso Rde C. Quality of life in patients with chronic kidney disease. Clinics. 2011;66(6):991-5.

PMid:21808864 PMCid:PMC3130152

Bayoumi M, Al Harbi A, Al Suwaida A, Al Ghonaim M, Al Wakeel J, Mishkiry A. Predictors of quality of life in hemodialysis patients. Saudi J Kidney Dis Transpl. 2013;24(2):254-9.


Peng YS, Huang JW, Hung KY, Lin BS, Lin CY, Yang CS, et al. Women on hemodialysis have lower self-reported health-related quality of life scores but better survival than men. J Nephrol. 2013;26(2):366-74.


Zhou, X., Xue, F., Wang, H., Qiao, Y., Liu, G., & Huang, L., Li D., Wang S., Wang Q., Li L. & Li R. The quality of life and associated factors in patients on maintenance hemodialysis - a multicenter study in Shanxi province. Renal Failure. 2017; 39(1): 707-711.

PMid:29141472 PMCid:PMC6446155

Megari K. Quality of Life in Chronic Disease Patients. Health Psychol Res. 2013;1(3):e27.

Pengpid S, Peltzer K. The Impact of Chronic Diseases on the Quality of Life of Primary Care Patients in Cambodia, Myanmar and Vietnam. Iran J Public Health. 2018;47(9):1308-1316.

How to Cite
Hakeem Ismael1N., & Omer Rashid, A. (2020). Health-Related Quality of Life in End-Stage Renal Disease Patients and Healthy Individuals. Galen Medical Journal, 9, e1987.
Original Article